Propranolol 10 mg Tablet PCD Franchise in Mumbai

Anti-Hypertensive Medicine Supplier in Delhi

Cardiology Tablet Distributor in Chennai

Blood Pressure Management Pharma Franchise in Pune

Propranolol Tablet Stockist in Kolkata
Beta-Blocker Therapy Tablet Export & Manufacturing in Hyderabad

Home/Products /propranolol-hydrochloride-ip-10-mg-tablet

Penpol 10 Tablet

Composition : Propranolol (10mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Penpol 10 Tablet contains Propranolol 10 mg, a non-selective beta-adrenergic blocker widely used to control hypertension, angina, and certain arrhythmias. It works by reducing heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and improving cardiovascular stability.

Belonging to the cardiology and antihypertensive segment, Propranolol is prescribed by general physicians and cardiologists for long-term management of cardiovascular conditions, as well as for prevention of migraines and anxiety-related tachycardia.

The tablet’s consistent efficacy and safety profile make it a high-demand medicine in hospitals, clinics, and retail pharmacies across India, ensuring recurring demand and strong market presence.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Penpol 10 Tablet offers a profitable B2B opportunity, serving the expansive cardiology segment with competitive pricing and steady institutional adoption.


Read More

About the Product

Penpol 10 Tablet contains Propranolol 10 mg, a non-selective beta-adrenergic blocker widely used to control hypertension, angina, and certain arrhythmias. It works by reducing heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and improving cardiovascular stability.

Belonging to the cardiology and antihypertensive segment, Propranolol is prescribed by general physicians and cardiologists for long-term management of cardiovascular conditions, as well as for prevention of migraines and anxiety-related tachycardia.

The tablet’s consistent efficacy and safety profile make it a high-demand medicine in hospitals, clinics, and retail pharmacies across India, ensuring recurring demand and strong market presence.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Penpol 10 Tablet offers a profitable B2B opportunity, serving the expansive cardiology segment with competitive pricing and steady institutional adoption.


Common side effects include fatigue, dizziness, cold hands or feet, slow heartbeat, or gastrointestinal discomfort. Rarely, it may cause severe bradycardia, hypotension, bronchospasm, or worsening of heart failure. Seek medical attention if severe symptoms occur.

Penpol 10 Tablet is indicated for the treatment of hypertension (high blood pressure), angina pectoris, certain types of arrhythmias, and prevention of migraine attacks. It helps reduce the risk of heart-related complications and improves overall cardiovascular health.

Take Penpol 10 Tablet exactly as prescribed. Do not stop the medication abruptly, as this may trigger heart complications. Inform your doctor if you have asthma, diabetes, heart block, or other heart-related conditions.

Store Penpol 10 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation